Lecanemab May Reverse Alzheimer's Disease But 3 Deaths Raise

The U.S. Food and Drug Administration (FDA) granted Leqembi accelerated approval on Jan. 6, 2023. It is the seventh ...

Related Keywords

Japan , Japanese , Stephanie Zhang , University Of Mississippi Medical Center , Drug Administration , Granted Anti Amyloid Drug , Improve Cognitive , Including Three , New England Journal , Memory Impairment , Neurodegenerative Dementia , Mississippi Medical , Alzheimer 039s Disease , Death , Fda , Lecanemab , Leqembi , Side Effect , The Epoch Times ,